The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Digital Mental Health Service for Non-Treatment Seeking Young Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04948268
Recruitment Status : Recruiting
First Posted : July 1, 2021
Last Update Posted : December 5, 2023
Sponsor:
Information provided by (Responsible Party):
David Mohr, Northwestern University

Brief Summary:

This is a feasibility trial of a personalized 8-week text messaging intervention aimed at young adults (ages 18-25) with depression and anxiety who are not interested in -- or experience barriers to -- receiving traditional face-to-face psychological treatments.

The trial will consist of a pilot test of (1) an 8-week adaptive (personalized) messaging intervention relative to (2) a non-personalized digital mental health intervention, or (3) an active control which will send weekly psychoeducation information by way of Uniform Resource Locators (URLs). The adaptive intervention will uses machine learning to tailor Short Message Service (SMS) messages to an individual's needs and preferences, and URL links to provide access to psychoeducational content to contextualize messages, when the length of that content exceeds the limitations of messages.

The primary goals of the project are to conduct a feasibility trial using a sequential multiple assignment randomized treatment (SMART) design, which will evaluate (a) the effectiveness of an adaptive, personalized messaging intervention in reducing engagement relative to a non-personalized version; and (b) whether human coaching results in greater symptom reduction and engagement, relative an unguided implementation.


Condition or disease Intervention/treatment Phase
Depression Anxiety Suicidal Ideation Behavioral: Adaptive messaging intervention Behavioral: Non-personalized messaging intervention Behavioral: Coaching Behavioral: Psychoeducational links Not Applicable

Detailed Description:

The primary purpose of this trial is to test the feasibility of conducting a randomized controlled trial of digital mental health intervention (DMHI) for non-treatment seeking young adults with symptoms of depression or anxiety, comparing an 8-week adaptive (personalized) messaging intervention, an 8-week non-personalized digital mental health intervention, or an active control which will deliver psychoeducational content via clickable URLs. The adaptive intervention will be powered by reinforcement learning to deliver tailored SMS messages based on user profiles and the ways in which a user interacts with the intervention system, along with links to longer psychoeducational content. The non-personalized intervention arm will not personalize the messages, but will still be an active treatment. This study will examine the adaptive intervention's ability to engage users and effectiveness in decreasing psychological distress relative to a non-personalized intervention. Participants who become disengaged (5 continuous days of not clicking on content URL links, responding to messages, or message ratings) from the adaptive or static intervention arms at any point in the first two weeks of treatment will be randomized to receive low-intensity human coaching or continue without coaching for the remainder of the intervention period.

Recruitment will take place via Mental Health America's (MHA) website. MHA is a large mental health advocacy organization that hosts online screeners and has large number of visitors the majority of whom meet clinical cutoffs for depressive or anxiety disorder symptoms. This study will enroll individuals who have completed a depression or anxiety disorder screener on MHA's website, and meet clinical cut-offs on the Patient Health Questionnaire - 9 (PHQ-9) or Generalized Anxiety Disorder - 7 (GAD-7).

Initial randomization will be generated in permuted blocks of 5 using a computer program. To prevent allocation bias, randomization will be conducted by the biostatistician, who will not inform the study team of the treatment arms until the baseline assessment has been completed and the patient has been enrolled. Second randomization of disengaged participants will occur as disengagement is detected during the first two weeks. Half (50%) of disengaged individuals will be randomized to receive additional human coaching throughout the remainder of the study while remaining in either the adaptive or non-personalized treatment arms. The disengaged participants not randomized to receive additional human coaching will continue to receive either the non-personalized or adaptive automated treatment the participants were randomized to initially.

Coaching will consist of providing users with support and accountability via positive reinforcement, goal and expectation setting, and monitoring. Coaching outreach will focus on adherence to the treatment but will not provide treatment advice. Coaches will provide a brief (15-minute phone call or equivalent depending on the medium) engagement session over the phone, SMS, or email, depending user preference. Thereafter, coaches will check in with participants via messaging, phone call, or email, twice per week and respond to patient texts.

Participants will be assessed using self-report measures at baseline, weeks 4, 8, 12, and 16 weeks.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 120 participants
Allocation: Randomized
Intervention Model: Sequential Assignment
Intervention Model Description: This study uses a sequential multiple assignment randomized trial (SMART) design. The first level of randomization is to one of the three treatment conditions: self-guided non-personalized intervention, self-guided adaptive intervention, or active control. The second level of randomization occurs during the first two weeks of intervention. Participants who meet criteria for disengagement from either the non-personalized or adaptive intervention are then randomized to receive coaching or continue as self-guided. This will provide the investigators with preliminary information on the need for and value of coaching. Participants will receive the assigned intervention from baseline to week 8, followed by an 8 week follow-up period
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Digital Mental Health Service for Non-Treatment Seeking Young Adults
Actual Study Start Date : October 23, 2023
Estimated Primary Completion Date : August 2024
Estimated Study Completion Date : December 2024

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Adaptive digital mental health intervention without coaching
The adaptive intervention will consist of SMS messages, symptom tracking, and psychological content that centers on evidence-based psychological strategies. Psychoeducational content will be delivered via a URL in an SMS message. Machine learning will be used to tailor messages and timing to meet participant preferences.
Behavioral: Adaptive messaging intervention
Psychological content and messages delivered regularly over an 8-week period via interactive SMS messages. Content and messages will be tailored using machine learning.

Experimental: Non-personalized digital Mental Health intervention without coaching
The non-personalized intervention will consist of SMS messages, symptom tracking, and psychological content that centers on evidence-based psychological strategies. Messages and content will not be tailored based on participants profile or usage.
Behavioral: Non-personalized messaging intervention
Psychological content and messages delivered regularly over an 8-week period via interactive SMS messages. Psychological content will center on a single psychological strategy each week. There will not be any tailoring of messaging and content based on group or individual level data.

Experimental: Adaptive digital mental health intervention with coaching
The adaptive intervention will consist of SMS messages, symptom tracking, and psychological content that centers on evidence-based psychological strategies. Psychoeducational content will be delivered via a URL in an SMS message. Machine learning will be used to tailor messages and timing to meet participant preferences. Coaching will be provided to support engagement and intervention use via medium of participants choice (texts, calls, or emails).
Behavioral: Adaptive messaging intervention
Psychological content and messages delivered regularly over an 8-week period via interactive SMS messages. Content and messages will be tailored using machine learning.

Behavioral: Coaching
Human coaching to support intervention use and engagement via telephone calls, text or email

Experimental: Non-personalized digital Mental Health intervention with coaching
The non-personalized intervention will consist of SMS messages, symptom tracking, and psychological content that centers on evidence-based psychological strategies. Messages and content will not be tailored based on participants profile or usage. Coaching will be provided to support engagement and intervention use via medium of participants choice (texts, calls, or emails).
Behavioral: Non-personalized messaging intervention
Psychological content and messages delivered regularly over an 8-week period via interactive SMS messages. Psychological content will center on a single psychological strategy each week. There will not be any tailoring of messaging and content based on group or individual level data.

Behavioral: Coaching
Human coaching to support intervention use and engagement via telephone calls, text or email

Active Comparator: Active control
The active control condition will provide brief text messages that include a URL link to psychoeducational content, but will not include the interactive messaging component described in experimental arms.
Behavioral: Psychoeducational links
SMS messages with URLs containing brief psychoeducational information.




Primary Outcome Measures :
  1. Kessler Psychological Distress Scale [ Time Frame: 16 weeks ]
    10-item self-report measure of transdiagnostic distress, used as outcome measure across diagnostic categories. Higher scores mean greater distress. Minimum score: 10; maximum score: 50

  2. Engagement length [ Time Frame: Up to 16 weeks ]
    Last message/content rating or click on content URL link received from participant.


Secondary Outcome Measures :
  1. Patient Health Questionnaire-9 [ Time Frame: 16 weeks ]
    10-item self-report measure assessing depression symptom severity. Higher scores mean greater symptom severity. Minimum score: 0; maximum score: 27

  2. Generalized Anxiety Disorder-7 [ Time Frame: 16 weeks ]
    8-item self-report measure assessing generalized anxiety disorder symptom severity Higher scores mean greater symptom severity. Minimum score: 0; maximum score: 21


Other Outcome Measures:
  1. Objective engagement markers [ Time Frame: 16 weeks ]
    Number of message & content ratings, and content URL clicks.

  2. Cognitive Behavioral Response to Stress Scale [ Time Frame: 16 weeks ]

    9-item self-report measure of behavioral and cognitive coping related skills. Higher scores indicate greater adaptive cognitive and behavioral skills use.

    Two domains: Use and usefulness. For each domain, minimum score: 0; maximum score: 54


  3. Depression Symptom Inventory - Suicidality Subscale [ Time Frame: 16 weeks ]

    4-item self-report questionnaire assessing the frequency and intensity of suicidal thoughts over previous two weeks.

    Higher scores signal greater frequency and severity of suicidal thoughts. Minimum score: 0; maximum score: 12




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 25 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Ages 18 to 25 *The age to provide consent in Nebraska is 19. Individuals recruited from the state of Nebraska must be 19 or older.
  2. A positive screen on an MHA screen for depression (Patient Health Questionnaire - 9 [PHQ-9]) or anxiety (Generalized Anxiety Disorder - 7 [GAD-7]);
  3. Resident of the United States.
  4. Owns a smartphone

Exclusion Criteria:

  1. Current treatment with psychotherapy or psychiatric medication management;
  2. Seeking or plans to seek traditional mental health treatment (psychotherapy or psychiatric medication management) in next 8 weeks;
  3. Serious mental illness for which intervention would be contraindicated (e.g., psychotic disorder, manic episode, etc.)
  4. Severe suicidality (i.e., experiencing suicidal ideation with a plan and intent to act);
  5. English insufficient to engage in design activities.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04948268


Contacts
Layout table for location contacts
Contact: Jonah Meyerhoff, PhD 312-503-1232 jonah.meyerhoff@northwestern.edu
Contact: David C. Mohr, PhD 312-503-1403 d-mohr@northwestern.edu

Locations
Layout table for location information
United States, Illinois
Northwestern University Recruiting
Chicago, Illinois, United States, 60611
Contact: Jonah Meyerhoff, PhD    312-503-1232    jonah.meyerhoff@northwestern.edu   
Contact: David C Mohr, PhD    312-503-1403    d-mohr@northwestern.edu   
Sponsors and Collaborators
Northwestern University
Investigators
Layout table for investigator information
Principal Investigator: David C Mohr, PhD Northwestern University
Layout table for additonal information
Responsible Party: David Mohr, Professor, Northwestern University
ClinicalTrials.gov Identifier: NCT04948268    
Other Study ID Numbers: R34MH124960 ( U.S. NIH Grant/Contract )
First Posted: July 1, 2021    Key Record Dates
Last Update Posted: December 5, 2023
Last Verified: December 2023
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes
Plan Description: De-identified data will be shared through and managed by the National Institute of Mental Health (NIMH) Data Archive (NDA). De-identified human subjects data, harmonized to a common standard, are available to qualified researchers.
Supporting Materials: Study Protocol
Time Frame: Data will be available after publication of the primary outcome papers.
Access Criteria: The NIMH Data Archive is managed by the NIMH. Access criteria are determined by the NIMH.
URL: https://nda.nih.gov/

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by David Mohr, Northwestern University:
Text messaging
Depression
Anxiety
Telemedicine
Digital Mental Health
mobile health (mHealth)
Mobile phone
Technology assisted
Smartphone
Cell phone
Coach
Additional relevant MeSH terms:
Layout table for MeSH terms
Depression
Suicidal Ideation
Behavioral Symptoms
Suicide
Self-Injurious Behavior